and used immediately.
CY Treatment and Yeast Infection in Mice
Mice were injected intraperitoneally with CY (Nakalai Tesque Inc., Kyoto, Japan) at a dose of 200 mg/kg. Two days after this injection, the mice (3-21/group) were injected intravenously via the tail vein with saline-washed viable yeast cells (1ϫ10 6 , 2ϫ10 6 , and 1ϫ10 7 ), which had been suspended in 0.2 ml of sterile saline after being counted with a hemocytometer. The animals were monitored for 20 d.
Viable Yeast Cells in Kidneys Two days after infection the mice (15/group) were divided into two groups: a severely debilitated group, in which death occured within 1 week; and a nondebilitated group. Animals in both groups were killed by exsanguination. The kidneys were removed and homogenized separately in sterile saline. The number of viable yeast cells in each homogenate was determined by plating on YSLM agar. Colonies were counted after 40-h incubation at 30°C. The number of viable cells in the organ was expressed as the number of colony-forming units (CFU).
Blood Sampling and Enzyme-Linked Immunosorbent Assay (ELISA) Two days after infection, the mice (15/ group) were divided into two groups as noted above, anesthetized with ethyl ether, and bled by cardiac puncture. Blood samples were collected in sterile tubes and allowed to clot at room temperature before centrifugation. Individual serum samples were then frozen at Ϫ20°C until assayed for TNF and IL-1 production. Factor-Test TM mTNF-a, Mouse Tumor Necrosis Factor ELISA Test Kit (Genzyme, Cambridge, MA, U.S.A., code #1509-00) was used for the measurement of TNF-a levels. The Inter Test-1aX TM Mouse IL-1 ELISA Kit (Genzyme, code #1900-01) was used for the measurement of IL-1-a levels. These ELISA cytokine assays were performed in duplicate and standards were included on each plate.
Statistical Analysis Statistical analysis of mortality was done using Fisher's exact test, and statistical analysis of CFU numbers and cytokine levels was done using Student's t-test. For all experiments, differences between CY-treated and nontreated groups were considered significant at pϽ0.05.
RESULTS AND DISCUSSION

Lethality of Yeast Strains to Mice
In a preliminary screening (3 mice/group), in which yeast cells (1ϫ10 6 and 1ϫ10 7 /mouse) were inoculated intravenously in CY-treated and nontreated groups, most mice in both groups manifested no signs of toxicity. However, one strain each of A. telluris, S. cerevisiae, and S. kluyveri provoked severe debilitation in CY-treated mice: the eyes were closed, breathing was labored, and behavior was arrested by infection with 1ϫ10 7 cells/mouse. It is well known that the strong immunosuppression provoked by CY does not significantly modify the susceptibility of the mice to Candida strains that show low or no pathogenicity in normal mice, and that this treatment greatly increases susceptibility to Candida strains that are apparently pathogenic in unmodified hosts. 10) Our results have shown that CY treatment modulates host susceptibility to experimental systemic infection with pathogenic strains of a variety of yeasts other than Candida. Therefore it is reasonable to conclude that diseases caused by Saccharomyces could occur in immunosuppressed patients with multiple underlying disorders and in subjects who have had prior courses of antibiotic therapy, as indeed has been demonstrated by several authors. [2] [3] [4] To investigate the lethal mechanisms of the yeast strains that were pathogenic in CY-treated mice, we inoculated CYtreated and nontreated mice with 2ϫ10 6 cells of C. albicans NIH B-792, and with 1ϫ10 7 cells of strains A. telluris IFO 1329, S. cerevisiae IFO 0718, and S. kluyveri IFO 1685. As shown in Fig. 1 , the numbers of CFU recovered from CYtreated debilitated mice infected with these four yeasts were significantly higher than those recovered from CY-nontreated infected and CY-treated infected nondebilitated mice (pϽ 0.05 and 0.01, respectively). The results for A. telluris IFO 1329, S. cerevisiae IFO 0718, and S. kluyveri IFO 1685 were very similar to that of C. albicans NIH B-792. The CFU number in all CY-treated and nontreated mice, which were all in a nondebilitated state, infected with A. telluris IFO 1330, S. cerevisiae IFO 0216, and S. cerevisiae IFO 1948 used as control nonpathogenic yeasts was very low. The CFU numbers appeared to parallel the lethality of the strains. These results led us to speculate that the accumulation of yeast cells in host organs is an important factor in the pathogenesis of infection with these cells.
5)
Serum Levels of TNF-a a and IL-1 It is known that the lethal consequences of septic shock are the result of an exaggerated host response, mediated by protein factors such as TNF-a and IL-1, rather than the result of the action of effectors originating from the pathogen. [12] [13] [14] [15] Levels of TNF-a and IL-1 in the sera of CY-treated debilitated mice infected with the four pathogenic yeasts were also significantly higher than those in CY-nontreated infected, CY-treated infected nondebilitated, and CY-treated noninfected mice, and normal control mice (pϽ0.05-0.001) (Fig. 2) , while the levels of these factors in the sera of all CY-treated mice infected with the three control nonpathogenic yeast strains were very low. All groups of debilitated CY-treated mice in which levels exceeding TNF-a 0.6 ng/ml and IL-1 50 pg/ml were detected in sera were dead by 1 week after infection. These results indicate that the toxicity of the yeast strains in mice was significantly correlated with serum levels of TNF-a and IL-1. The release of TNF may be related to its capacity to activate the effector function controlling Candida growth under some conditions. 6, 9) On the other hand, it has also been reported that TNF-a induced in mice by C. albicans is involved in the increase in fibrinogen, an acute-phase protein, and that fibrinogen levels showed relatively sensitive changes correlated with those (about 500 pg/ml) in TNF-a. 7) Recently, it has also been shown that TNF-a reduces neutrophil fungicidal activity to less than 40% of that manifested by unprimed control cells. 8) Taken together, our present results suggest that extensive levels of TNF-a and IL-1 in serum later during infection correlate with susceptibility. Further studies are required to clarify the overall mechanism involved in yeast infections.
To our knowledge, this was the first demonstration of the lethality of low pathogenic yeasts in immunocompromised mice. We postulate that the living cells of some strains of a variety of yeasts circulating through the body evoke the lethality in mice via accumulation in the host organ (Fig. 1 ) and the production of factors such as the cytokines, TNF-a, and IL-1 (Fig. 2) . Exposure to viable yeast cells in humans is being increased due to the eating of certain fermented foods, and by the large-scale use of yeasts such as in recombinant protein production. Our findings emphasize the importance of monitoring yeasts in the environment and of the selection of suitable yeast strains in recombinant protein production, as well as the importance of key factors involved the immunological condition of hosts, in preventing this novel risk posed by yeasts of relatively low pathogenicity.
